Initiation of the gonadotropin-releasing hormone antagonist ganirelix for in vitro fertilization cycles in which the lead follicle is >14 mm.
The initiation of GnRH antagonists when the lead follicle is >14 mm does not adversely affect IVF success rates and leads to a shortened duration of GnRH antagonist administration.
Klipstein
Sigal
S
Reindollar
Richard H
RH
Regan
Meredith M
MM
Alper
Michael M
MM
D000328:Adult; D005260:Female; D005307:Fertilization in Vitro; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D006801:Humans; D007247:Infertility, Female / Q000000981:diagnostic imaging / Q000628:therapy*; D006080:Ovarian Follicle / Q000000981:diagnostic imaging*; D014463:Ultrasonography
D007987:Gonadotropin-Releasing Hormone; C061018:ganirelix